title: Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation.
authors.forename: S
authors.initials: S
authors.lastname: Merante
authors.forename: A A
authors.initials: AA
authors.lastname: Colombo
authors.forename: S
authors.initials: S
authors.lastname: Calatroni
authors.forename: B
authors.initials: B
authors.lastname: Rocca
authors.forename: M
authors.initials: M
authors.lastname: Boni
authors.forename: P
authors.initials: P
authors.lastname: Bernasconi
authors.forename: L
authors.initials: L
authors.lastname: Bonvini
authors.forename: S
authors.initials: S
authors.lastname: Soverini
authors.forename: E P
authors.initials: EP
authors.lastname: Alessandrino
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000601:surgery / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D014019:Tissue Donors; D018183:Transplantation Chimera
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate